You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.



Personalized Management for the Diabetes Patient in Primary Care

  • Authors: Juan Gorgojo-Martinez, MD
  • CPD Released: 12/9/2021
  • Valid for credit through: 12/9/2022, 11:59 PM EST
Start Activity

Target Audience and Goal Statement

This educational activity is intended for an international audience of non-US and non-UK primary care physicians, cardiologists, diabetologists, and endocrinologists.

The goal of this activity is to advance the guideline-endorsed principle of personalized management of patients with type 2 diabetes (T2D) in primary care.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Specific guideline recommendations for the early preferred use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) in certain patients with T2D
  • Have greater competence related to
    • Early identification of appropriate patients with T2D for injectable or oral GLP-1 RA therapy


WebMD Global requires each individual who is in a position to control the content of one of its educational activities to disclose any relevant financial relationships occurring within the past 12 months that could create a conflict of interest.


  • Juan Gorgojo-Martinez, MD

    Head of Department
    Unit of Endocrinology and Nutrition
    Hospital Universitario Fundación Alcorcón
    Madrid, Spain


    Disclosure: Juan Gorgojo-Martinez, MD, has the following relevant financial relationships:
    Advisor or consultant for: AstraZeneca; Eli Lilly and Company; Mundipharma; Novo Nordisk
    Speaker or a member of a speakers bureau for: Abbott; AstraZeneca; Boehringer Ingelheim; Esteve; Janssen; Eli Lilly and Company; MSD; Mundipharma; Novo Nordisk; Roche
    Grants for clinical research from: Novo Nordisk


  • Marcel Meijer, PhD

    Senior Director, Content Development, WebMD Global, LLC


    Disclosure: Marcel Meijer, PhD, has disclosed no relevant financial relationships.

  • Gina Montanero, PharmD

    Associate Medical Writer, Medscape, LLC


    Disclosure: Gina Montanero, PharmD, has disclosed no relevant financial relationships.

Content Reviewer

  • Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP

    Associate Director, Accreditation and Compliance


    Disclosure: Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP, has disclosed no relevant financial relationships.

None of the nonfaculty planners for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.

Accreditation Statements

    For Physicians

  • The Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom (FPM) has reviewed and approved the content of this educational activity and allocated it 0.75 continuing professional development credits (CPD).

    Contact WebMD Global

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information about your eligibility to claim credit, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent participating in the activity. To successfully earn credit, participants must complete the activity online during the credit eligibility period that is noted on the title page.

Follow these steps to claim a credit certificate for completing this activity:

  1. Read the information provided on the title page regarding the target audience, learning objectives, and author disclosures, read and study the activity content and then complete the post-test questions. If you earn a passing score on the post-test and we have determined based on your registration profile that you may be eligible to claim CPD credit for completing this activity, we will issue you a CPD credit certificate.
  2. Once your CPD credit certificate has been issued, you may view and print the certificate from your CME/CE Tracker. CPD credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of the Medscape Education homepage.

We encourage you to complete an Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.

*The credit that you receive is based on your user profile.


Personalized Management for the Diabetes Patient in Primary Care

Authors: Juan Gorgojo-Martinez, MDFaculty and Disclosures

CPD Released: 12/9/2021

Valid for credit through: 12/9/2022, 11:59 PM EST


The following cases are modeled on the interactive grand rounds approach. The questions within the activity are designed to test your current knowledge. After each question, you will be able to see whether you answered correctly and read evidence-based information that supports the most appropriate answer choice. The questions are designed to challenge you; you will not be penalized for answering the questions incorrectly. At the end of the activity, there will be a short post-test assessment based on the material presented.


Benjamin is a 58-year-old government official with a 2-year history of type 2 diabetes (T2D) and stable angina after a myocardial infarction (MI) 4 years ago which required a stent in the anterior descending coronary artery. He has come to the primary care office today for his annual check-up and to review his recent laboratory results. His medical history and the results of his physical exam and laboratory tests are shown in Table 1.

You note that his blood pressure (BP) is 148/98 mmHg despite adherence to an angiotensin converting enzyme inhibitor and beta-blocker. His glycated hemoglobin (HbA1c) is 6.8% on metformin. His kidney function is good, with no sign of albuminuria.

Table 1. Benjamin’s Medical Record




T2D x 2 years, stable angina from MI 4 years ago, HTN x 10 years, dyslipidemia x 7 years, and obesity

Current medications

Metformin 1000 mg twice daily, lisinopril 20 mg/d, metoprolol 100 mg twice daily, simvastatin 20 mg/d, ezetimibe 10mg/d, acetylsalicylic acid 100 mg/d


Government official, married, lives with wife and dog; non-smoker, non-drinker; has 2 adult sons. Sedentary lifestyle. High-fat diet, poor intake of fruit, vegetables, and whole grains

Physical Exam


Vital signs

BP: 148/98 mmHg

HR: 78 bpm

Body measurements

Weight: 85.2 kg, waist circumference: 108 cm, BMI: 32 kg/m2; class 1 obesity


No edema


No distended neck veins


LVEF: 60%


No rales


Soft, nontender





Metabolic Panel



122 mg/dL



Lipid panel

LDL: 75 mg/dL; HDL: 35 mg/dL, TG: 155 mg/dL


91 mL/min/m2


9 mg/g

BMI, body mass index; CBC, complete blood count; eGFR, estimated glomerular filtration rate; FPG, fasting plasma glucose; HDL, high density lipoprotein; HTN, hypertension; HR, heart rate; LVEF, left ventricular ejection fraction; LDL, low density lipoprotein; TG, triglycerides; UACR, urine albumin-to-creatinine ratio.
  • Print